Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|August 21, 2018
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort studyClaire Auzolle, Stephane Nancey, My-Linh Tran-Minh, et al.Inflammatory Bowel Diseases|November 16, 2016
Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 YearsGilles Boschetti, Stephane Nancey, Fady Daniel, et al.Alimentary Pharmacology & Therapeutics|March 24, 2020
Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort studyMarianne Hupé, Pauline Rivière, Stephane Nancey, et al.Inflammatory Bowel Diseases|March 21, 2013
Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseasesStephane Nancey, Gilles Boschetti, Driffa Moussata, et al.The American Journal of Gastroenterology|March 18, 2015
Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's DiseaseGilles Boschetti, Marc'harid Laidet, Driffa Moussata, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2018
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative ColitisGauthier Pellet, Carmen Stefanescu, Franck Carbonnel, et al.Therapeutic Advances in Gastroenterology|May 17, 2021
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international surveyTamás Resál, Renáta Bor, Kata Szántó, et al.Journal of Crohn'S & Colitis|May 22, 2016
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative ColitisRaja Atreya, Stuart Bloom, Franco Scaldaferri, et al.Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.Alimentary Pharmacology & Therapeutics|August 3, 2018
Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)Charlotte Gagnière, Anne Bourrier, Philippe Seksik, et al.Pageof 6